Preview

Journal of Siberian Medical Sciences

Advanced search

Evaluation of the effectiveness of the third stage rehabilitation in patients after COVID-19 in a day hospital

https://doi.org/10.31549/2542-1174-2023-7-2-17-28

Abstract

I n t r o d u c t i o n . For patients with the consequences of COVID-19 it seems relevant to undergo a rehabilitation program to restore the respiratory function, oxygen uptake by tissues, increase exercise tolerance, etc. Rehabilitation includes aerobic-based exercises adequate to the patient’s state and physical capabilities, breathing exercises and physiotherapy modalities.

A i m . To evaluate the effectiveness of the third stage rehabilitation in patients aged 18–45 years with the consequences of COVID-19 (U07.1) in a day hospital of multispecialty hospital.

M a t e r i a l s a n d m e t h o d s . One hundred and thirty-nine patients aged 18–45 years with a verified diagnosis of pneumonia associated with COVID-19 (U07.1) were examined in a day hospital of multispecialty hospital. The patients were divided into 2 groups: 107 patients of the 1st group underwent the third stage rehabilitation; 32 people from who made up the 2nd group refused rehabilitation. The severity of dyspnea was assessed using the Medical Research Council (MRC) Dyspnea Scale; functional impairment in the performance of activities of daily living – according to the Baseline Dyspnea Index and Transitional Dyspnea Index scales; exercise tolerance – according to the 6-minute walk test and the modified Borg Scale; the severity of anxiety and depression – according to the Hospital Anxiety and Depression Scale (HADS); pain intensity – according to the Visual Analogue Scale (VAS); quality of life – according to the EuroQoL Five-Dimension Questionnaire (EQ-5D). Statistical processing of the obtained results was carried out.

R e s u l t s . In the group of patients who completed rehabilitation, upon follow-up examination, there was a significant decrease in complaints, normalization of a number of hemodynamic parameters, an improvement in the 6-minute walk test scores, a decrease in the severity of dyspnea according to the MRC Dyspnea Scale by 1.8 times, a decrease in anxiety according to the HADS by 2.1 times, a decrease in pain according to the VAS by 3.2 times, an improvement in exercise tolerance according to the modified Borg Scale by 1.8 times and quality of life – according to the EQ-5D by 1.4 times. In the group of patients who refused rehabilitation, the change in these indicators was not significant.

C o n c l u s i o n . For patients who have had pneumonia associated with SARS-CoV-2, it is advisable to go through the third stage rehabilitation in a day hospital in order to restore the respiratory functions, increase exercise tolerance, reduce anxiety and improve quality of life.

About the Authors

V. A. Drobyshev
Novosibirsk State Medical University
Russian Federation

Viktor A. Drobyshev – Dr. Sci. (Med.), Professor, Department of Hospital Therapy and Medical Rehabilitation

52, Krasny prosp., Novosibirsk, 630091



L. A. Shpagin
Novosibirsk State Medical University
Russian Federation

Lyubov A. Shpagina – Dr. Sci. (Med.), Professor, Head, Department of Hospital Therapy and Medical Rehabilitation

Novosibirsk



S. А. Karmanovskaya
Novosibirsk State Medical University
Russian Federation

Svetlana A. Karmanovskaya – Dr. Sci. (Med.), Associate Professor, Department of Hospital Therapy and Medical Rehabilitation

Novosibirsk



N. A. Sukhaterina
City Clinical Hospital No. 2
Russian Federation

Natalya A. Sukhaterina – Cand. Sci. (Med.), General Practitioner

Novosibirsk



E. A. Zaikina
City Clinical Hospital No. 2
Russian Federation

Ekaterina A. Zaikina – Physical Medicine Physician

Novosibirsk



References

1. Medical rehabilitation for a novel coronavirus infection (COVID-19). Version 2 (31.07.2020). Interim guidelines. (2020). URL: https://edu.rosminzdrav.ru/fileadmin/user_upload/specialists/COVID-19/dopmaterials/VMR_medreabilitacija_COVID_versija2.pdf (accessed 06.12.2022).

2. Brann D.H., Tsukahara T., Weinreb C. et al. Non-neuronal expression of SARS-CoV-2 entry genes in the olfactory system mechanisms underlying COVID-19- associated anosmia // bioRχiv. 2020;6(31):1-19. DOI: 10.1101/2020.03.25.009084.

3. Li Y.C., Bai W.Z., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. Med. Virol. 2020;92(6):552-555. DOI: 10.1002/jmv.25728.

4. Wu Y., Xu X., Chen Z. et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav. Immun. 2020;87:18-22. DOI: 10.1016/j.bbi.2020.03.031.

5. Yang X., Yu Y., Xu J. et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir. Med. 2020;8(5):475- 481. DOI: 10.1016/S2213-2600(20)30079-5.

6. Handbook of COVID-19. Prevention and Treatment / T. Liang, H. Cai, Y. Chen et al. 2020. URL: https://www.researchgate.net/publication/339998871_Handbook_of_COVID-19_Prevention_and_Treatment (accessed 06.12.2022).

7. Vitacca M., Carone M., Clini E.M. et al. Joint statement on the role of respiratory rehabilitation in the COVID-19 crisis: the Italian position paper. Respiration. 2020;99(6):493-499. DOI: 10.1159/000508399.

8. Brugliera L., Spina A., Castellazzi P. et al. Rehabilitation of COVID-19 patients. J. Rehab. Med. 2020;52(4):jrm00046. DOI: 10.2340/16501977-2678.

9. Huang L., Lin G., Tang L. et al. Special attention to nurses’ protection during the COVID-19 epidemic. Crit. Care. 2020;24:120. DOI: 10.1186/s13054-020-2841-7.

10. Guidelines 3.1.0170-20. 3.1. Prevention of infectious diseases. Epidemiology and prevention of COVID-19. Guidelines (approved by Chief Public Health Physician of the Russian Federation on 30.03.2020) (ed. from 30.04.2020). 2020. URL: http://www.consultant.ru/document/cons_doc_LAW_350140/ (accessed 06.12.2022). (In Russ.)

11. Zhao H.M., Xie Y.X., Wang C. Recommendations for respiratory rehabilitation in adults with coronavirus disease 2019. Chin. Med. J. 2020;133(13):1595-1602. DOI: 10.1097/CM9.0000000000000848.

12. Belkin А.А., Avdyunina I.A., Varako N.A. et al. Rehabilitation in intensive care. Clinical guidelines. Bulletin of Rehabilitation Medicine. 2017;2(78):139-143. (In Russ.)

13. Anesthesiology and resuscitation for patients with a novel coronavirus infection COVID-19. Guidelines, version No. 2 dated 18.04.2020 / Federation of Anesthesiologists and Untensive Care Practitioners. URL: http://mzdnr.ru/system/files/air_obespechenie_patsientov_s_covid_19_versia_18_04.pdf (accessed 06.12.2022). (In Russ.)

14. Stam H.J., Stucki G., Bickenbach J. Covid-19 and post intensive care syndrome: a call for action. J. Rehabil. Med. 2020;52(4):jrm00044. DOI: 10.2340/16501977-2677.

15. Ceravolo M.G., Arienti C., De Sire A. et al. Rehabilitation and Covid-19: the Cochrane Rehabilitation 2020 rapid living systematic review. Eur. J. Phys. Rehabil. Med. 2020;56(5):642-651. DOI: 10.23736/S1973-9087.20.06501-6.

16. Butland R.J., Pang J., Gross E.R. et al. Two-, six, and 12-minute walking tests in respiratory disease. Br. Med. J. (Clin. Res. Ed.). 1982;284:1607-1608. DOI: 10.1136/bmj.284.6329.1607.

17. Borg G.A. Psychophysical bases of perceived exertion. Med. Sci. Sports Exerc. 1982;14(5):377-381. DOI: 10.1249/00005768-198205000-00012.

18. Prisnie J.C., Fiest K.M., Coutts S.B. et al. Validating screening tools for depression in stroke and transient ischemic attack patients. Int. J. Psychiatry Med. 2016;51(3):262-277. DOI: 10.1177/0091217416652616.

19. EuroQol Group. EuroQol – a new facility for the measurement of health-related quality of life. Health Policy. 1990;16(3):199-208. DOI: 10.1016/0168-8510(90)90421-9.


Review

For citations:


Drobyshev V.A., Shpagin L.A., Karmanovskaya S.А., Sukhaterina N.A., Zaikina E.A. Evaluation of the effectiveness of the third stage rehabilitation in patients after COVID-19 in a day hospital. Journal of Siberian Medical Sciences. 2023;(2):17-28. (In Russ.) https://doi.org/10.31549/2542-1174-2023-7-2-17-28

Views: 159


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2542-1174 (Print)